tradingkey.logo

Merit Medical Systems Inc

MMSI
88.330USD
+0.780+0.89%
Close 11/10, 16:00ETQuotes delayed by 15 min
5.24BMarket Cap
44.22P/E TTM

Merit Medical Systems Inc

88.330
+0.780+0.89%

More Details of Merit Medical Systems Inc Company

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Its segments include cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (OEM). Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures. Its product portfolio of medical devices and accessories used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its electrophysiology and cardiac rhythm management portfolio includes steerable and other specialty technologies.

Merit Medical Systems Inc Info

Ticker SymbolMMSI
Company nameMerit Medical Systems Inc
IPO dateSep 16, 1954
CEO- -
Number of employees7400
Security typeOrdinary Share
Fiscal year-endSep 16
Address1600 West Merit Park Way
CitySOUTH JORDAN
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code84095
Phone18012531600
Websitehttps://www.merit.com/
Ticker SymbolMMSI
IPO dateSep 16, 1954
CEO- -

Company Executives of Merit Medical Systems Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.15M
+3.09%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%
Mr. Neil W. Peterson
Mr. Neil W. Peterson
Chief Operating Officer
Chief Operating Officer
16.61K
--
Rear Adm. (Retd.) Stephen C. Evans
Rear Adm. (Retd.) Stephen C. Evans
Independent Director
Independent Director
6.81K
+46.21%
Mr. Michael R. (Mike) McDonnell, CPA
Mr. Michael R. (Mike) McDonnell, CPA
Independent Director
Independent Director
3.96K
-30.63%
Dr. F. Ann Millner, Ed.D.
Dr. F. Ann Millner, Ed.D.
Lead Independent Director
Lead Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Fred P. Lampropoulos
Mr. Fred P. Lampropoulos
Chairman of the Board
Chairman of the Board
1.15M
+3.09%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
36.03K
+6.35%
Mr. Brian G. Lloyd
Mr. Brian G. Lloyd
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
21.70K
-44.35%
Ms. Martha Goldberg Aronson, Jr.
Ms. Martha Goldberg Aronson, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
19.59K
--
Mr. David K. Floyd
Mr. David K. Floyd
Independent Director
Independent Director
18.58K
+13.10%
Mr. Lonny J. Carpenter
Mr. Lonny J. Carpenter
Independent Director
Independent Director
17.37K
+14.14%

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%
By RegionUSD
Name
Revenue
Proportion
United States
227.08M
59.37%
International
155.38M
40.63%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Peripheral Intervention
142.85M
37.35%
Cardiac Intervention
115.25M
30.13%
Custom Procedural Solutions
53.63M
14.02%
OEM
52.29M
13.67%
Endoscopy devices
18.44M
4.82%

Shareholding Stats

Updated: Wed, Nov 5
Updated: Wed, Nov 5
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.45%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.74%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.07%
Other
64.87%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.45%
The Vanguard Group, Inc.
11.18%
State Street Investment Management (US)
3.74%
Conestoga Capital Advisors, LLC
3.69%
Fuller & Thaler Asset Management Inc.
3.07%
Other
64.87%
Shareholder Types
Shareholders
Proportion
Investment Advisor
56.82%
Investment Advisor/Hedge Fund
33.45%
Hedge Fund
11.03%
Research Firm
2.43%
Individual Investor
2.37%
Bank and Trust
2.04%
Pension Fund
1.65%
Sovereign Wealth Fund
1.02%
Family Office
0.41%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
736
64.29M
108.43%
-3.60M
2025Q2
756
65.62M
110.80%
-760.05K
2025Q1
779
66.66M
112.79%
+221.37K
2024Q4
755
63.98M
108.78%
+576.77K
2024Q3
725
62.16M
106.75%
-1.49M
2024Q2
695
63.02M
108.42%
-345.52K
2024Q1
677
61.08M
105.16%
-692.46K
2023Q4
651
59.77M
103.51%
-88.47K
2023Q3
637
57.87M
100.40%
-723.38K
2023Q2
625
56.54M
98.35%
-2.22M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
7.97M
13.46%
-206.62K
-2.53%
Jun 30, 2025
The Vanguard Group, Inc.
6.82M
11.51%
+257.10K
+3.92%
Jun 30, 2025
State Street Investment Management (US)
2.22M
3.75%
+24.57K
+1.12%
Jun 30, 2025
Conestoga Capital Advisors, LLC
2.21M
3.73%
-53.58K
-2.37%
Jun 30, 2025
Fuller & Thaler Asset Management Inc.
1.82M
3.07%
+52.67K
+2.98%
Jun 30, 2025
Macquarie Investment Management
1.46M
2.46%
+4.15K
+0.29%
Jun 30, 2025
Fidelity Management & Research Company LLC
1.45M
2.44%
-24.93K
-1.69%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.44M
2.43%
+39.62K
+2.83%
Jun 30, 2025
Two Sigma Investments, LP
1.40M
2.37%
+364.22K
+35.02%
Jun 30, 2025
Maverick Capital, Ltd.
1.38M
2.33%
+106.90K
+8.40%
Jun 30, 2025
View more

Related ETFs

Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
Invesco S&P SmallCap Health Care ETF
3.13%
First Trust Indxx Medical Devices ETF
1.7%
SPDR S&P Health Care Equipment ETF
1.54%
Thrivent Small-Mid Cap ESG ETF
0.91%
Invesco S&P SmallCap Low Volatility ETF
0.71%
SPDR S&P 600 Small Cap Growth ETF
0.67%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.67%
Franklin US Small Cap Multifactor Index ETF
0.65%
iShares S&P Small-Cap 600 Growth ETF
0.62%
OneAscent Small Cap Core ETF
0.62%
View more
Invesco S&P SmallCap Health Care ETF
Proportion3.13%
First Trust Indxx Medical Devices ETF
Proportion1.7%
SPDR S&P Health Care Equipment ETF
Proportion1.54%
Thrivent Small-Mid Cap ESG ETF
Proportion0.91%
Invesco S&P SmallCap Low Volatility ETF
Proportion0.71%
SPDR S&P 600 Small Cap Growth ETF
Proportion0.67%
Vanguard S&P Small-Cap 600 Growth Index Fund
Proportion0.67%
Franklin US Small Cap Multifactor Index ETF
Proportion0.65%
iShares S&P Small-Cap 600 Growth ETF
Proportion0.62%
OneAscent Small Cap Core ETF
Proportion0.62%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI